Invitrogen™ Human LGI2 Synthetic Peptide
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
- Gene ID (Enter)
- 55203
- Species
- Human
- Purification method
- Purified
- Accession number
- Q8N0V4
- Common name
- Human LGI2
- Brand
- Invitrogen
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15358770 |
| Specifications | |
| Gene ID (Enter) | 55203 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q8N0V4 |
| Common name | Human LGI2 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | LGI2 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0613 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |